{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T12:11:34Z","timestamp":1783685494859,"version":"3.55.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.ijpharm.2015.08.048","type":"journal-article","created":{"date-parts":[[2015,8,21]],"date-time":"2015-08-21T22:49:42Z","timestamp":1440197382000},"page":"162-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Nanoliposome-mediated targeting of antibodies to tumors: IVIG antibodies as a model"],"prefix":"10.1016","volume":"495","author":[{"given":"Amin Reza","family":"Nikpoor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalil","family":"Tavakkol-Afshari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Gholizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayvan","family":"Sadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hossein","family":"Babaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamshidkhan","family":"Chamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Badiee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Amir","family":"Jalali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud Reza","family":"Jaafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2015.08.048_bib0005","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijpharm.2014.07.020","article-title":"The influence of phospholipid on the physicochemical properties and anti-tumor efficacy of liposomes encapsulating cisplatin in mice bearing C26 colon carcinoma","volume":"473","author":"Alavizadeh","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0010","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ijpharm.2013.10.018","article-title":"Improvement of pharmacokinetic and antitumor activity of PEGylated liposomal doxorubicin by targeting with N-methylated cyclic RGD peptide in mice bearing C-26 colon carcinomas","volume":"458","author":"Amin","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0015","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0378-5173(02)00703-2","article-title":"Circulation and biodistribution profiles of long-circulating PEG-liposomes of various sizes in rabbits","volume":"253","author":"Awasthi","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0020","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1096\/fasebj.8.2.8119493","article-title":"Protection against doxorubicin-induced alopecia in rats by liposome-entrapped monoclonal antibodies","volume":"8","author":"Balsari","year":"1994","journal-title":"FASEB J."},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0025","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae\u2014the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0030","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0021-9258(18)70226-3","article-title":"Phosphorus assay in column chromatography","volume":"234","author":"Bartlett","year":"1959","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0035","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1021\/la950665s","article-title":"Changes in the secondary structure of adsorbed IgG and F (ab\u2032) 2 studied by FTIR spectroscopy","volume":"12","author":"Buijs","year":"1996","journal-title":"Langmuir"},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0040","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/bip.360250307","article-title":"Examination of the secondary structure of proteins by deconvolved FTIR spectra","volume":"25","author":"Byler","year":"1986","journal-title":"Biopolymers"},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0045","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nri1837","article-title":"Potent antibody therapeutics by design","volume":"6","author":"Carter","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0050","first-page":"49","article-title":"Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy","volume":"7","author":"Chang","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0055","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1021\/bi00772a015","article-title":"Determination of the secondary structures of proteins by circular dichroism and optical rotatory dispersion","volume":"11","author":"Chen","year":"1972","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0060","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1158\/1535-7163.1493.3.11","article-title":"Biological impediments to monoclonal antibody-based cancer immunotherapy","volume":"3","author":"Christiansen","year":"2004","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0065","first-page":"4804","article-title":"In vivo biodistribution of a humanized anti-Lewis Y monoclonal antibody (hu3S193) in MCF-7 xenografted BALB\/c nude mice","volume":"60","author":"Clarke","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0070","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0378-5173(02)00680-4","article-title":"Pulmonary administration of IgG loaded liposomes for passive immunoprophylaxy","volume":"254","author":"Dreffier","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0075","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.addr.2010.04.009","article-title":"The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect","volume":"63","author":"Fang","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0080","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/bdd.511","article-title":"Biodistribution of liposome-entrapped human gamma-globulin","volume":"27","author":"Garc\u00eda-Santana","year":"2006","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0085","first-page":"13","article-title":"CTLA-4 blockade in tumor models: an overview of preclinical and translational research","author":"Grosso","year":"2013","journal-title":"Cancer Immun."},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0090","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrd3003","article-title":"The safety and side effects of monoclonal antibodies","volume":"9","author":"Hansel","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0095","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1002\/ange.200900111","article-title":"Disterolphospholipids: nonexchangeable lipids and their application to liposomal drug delivery","volume":"121","author":"Huang","year":"2009","journal-title":"Angew. Chem."},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0100","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nrclinonc.2010.139","article-title":"Delivering nanomedicine to solid tumors","volume":"7","author":"Jain","year":"2010","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0105","series-title":"Immunochemistry in Practice","author":"Johnstone","year":"1996"},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0110","first-page":"277","article-title":"Treatment and side effect management of CTLA-4 antibody therapy in metastatic melanoma","volume":"9","author":"K\u00e4hler","year":"2011","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0115","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2165\/11531280-000000000-00000","article-title":"Clinical pharmacokinetics of therapeutic monoclonal antibodies","volume":"49","author":"Keizer","year":"2010","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0120","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1042\/bj1860591","article-title":"Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro","volume":"186","author":"Kirby","year":"1980","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0125","doi-asserted-by":"crossref","first-page":"7385","DOI":"10.1073\/pnas.0811427106","article-title":"Examination of the contributions of size and avidity to the neutralization mechanisms of the anti-HIV antibodies b12 and 4E10","volume":"106","author":"Klein","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jconrel.2004.07.033","article-title":"Anti-neovascular therapy by use of tumor neovasculature-targeted long-circulating liposome","volume":"100","author":"Maeda","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0135","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0022-2836(80)90252-1","article-title":"Crystallographic refinement and atomic models of the intact immunoglobulin molecule Kol and its antigen-binding fragment at 3.0\u00c5 and 1.9\u00c5 resolution","volume":"141","author":"Marquart","year":"1980","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0140","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature10673","article-title":"Cancer immunotherapy comes of age","volume":"480","author":"Mellman","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0145","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1023\/A:1011986613392","article-title":"A new look at lipid-membrane structure in relation to drug research","volume":"15","author":"Mouritsen","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0150","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1620\/tjem.185.89","article-title":"Biodistribution study of murine monoclonal anti-GD3 antibody in nude mice bearing human melanoma xenografts for development of immunoscintigraphy","volume":"185","author":"Ojima","year":"1998","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0155","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1098\/rstb.2004.1500","article-title":"Protein structure, stability and solubility in water and other solvents","volume":"359","author":"Pace","year":"2004","journal-title":"Philos. Trans. R. Soc. Lond. B: Biol. Sci."},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0160","first-page":"5694","article-title":"High-specific-activity 111In-labeled anticarcinoembryonic antigen monoclonal antibody: improved method for the synthesis of diethylenetriaminepentaacetic acid conjugates","volume":"45","author":"Paxton","year":"1985","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0165","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/705265","article-title":"Recent trends in multifunctional liposomal nanocarriers for enhanced tumor targeting","volume":"2013","author":"Perche","year":"2013","journal-title":"J. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0170","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1055\/s-0032-1328363","article-title":"Antitumor activity of PEGylated nanoliposomes containing crocin in mice bearing C26 colon carcinoma","volume":"79","author":"Rastgoo","year":"2013","journal-title":"Planta Med."},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0175","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/nbt0905-1073","article-title":"Monoclonal antibody successes in the clinic","volume":"23","author":"Reichert","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0180","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/jlcr.1600","article-title":"Synthesis and biodistribution studies of iodine-131 d-amino acid YYK peptide as a potential therapeutic agent for labeling an anti-CD20 antibody","volume":"52","author":"Sadri","year":"2009","journal-title":"J. Labelled Compd. Radiopharm."},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0185","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/MNM.0b013e3283419523","article-title":"PET imaging of EGFR expression in nude mice bearing MDA-MB-468, a human breast adenocarcinoma","volume":"32","author":"Sadri","year":"2011","journal-title":"Nucl. Med. Commun."},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0190","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/biot.200500044","article-title":"Cancer immunotherapy","volume":"1","author":"Schuster","year":"2006","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0195","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nrc3236","article-title":"Antibody therapy of cancer","volume":"12","author":"Scott","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0200","first-page":"55","article-title":"Tissue distribution of 125I-human nonspecific polyclonal IgG in normal and induced inflammation mice","author":"Shahhosseini","year":"2010","journal-title":"Iran. J. Pharm. Res."},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0205","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1271\/bbb.57.1445","article-title":"Encapsulation of chicken egg yolk immunoglobulin G (IgY) by liposomes","volume":"57","author":"Shimizu","year":"1993","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0210","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1006\/abio.2000.4880","article-title":"Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set","volume":"287","author":"Sreerama","year":"2000","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0215","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.biologicals.2005.06.007","article-title":"The effect of solvent environment on the conformation and stability of human polyclonal IgG in solution","volume":"34","author":"Szenczi","year":"2006","journal-title":"Biologicals"},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0220","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1208\/s12248-009-9157-5","article-title":"Biodistribution mechanisms of therapeutic monoclonal antibodies in health and disease","volume":"12","author":"Tabrizi","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0225","series-title":"Liposomes: a Practical Approach","author":"Torchilin","year":"2003"},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0230","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0006-3495(00)76602-1","article-title":"The thermal stability of immunoglobulin: unfolding and aggregation of a multi-domain protein","volume":"78","author":"Vermeer","year":"2000","journal-title":"Biophys. J."},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-4165(98)00048-8","article-title":"Structural changes of IgG induced by heat treatment and by adsorption onto a hydrophobic Teflon surface studied by circular dichroism spectroscopy","volume":"1425","author":"Vermeer","year":"1998","journal-title":"Biochim. Biophys. Acta (BBA)-Gen. Subj."},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0240","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nm0303-269","article-title":"Immunotherapy: past, present and future","volume":"9","author":"Waldmann","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0245","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-med-040210-162544","article-title":"Nanoparticle delivery of cancer drugs","volume":"63","author":"Wang","year":"2012","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0250","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nri2744","article-title":"Monoclonal antibodies: versatile platforms for cancer immunotherapy","volume":"10","author":"Weiner","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijpharm.2015.08.048_bib0255","first-page":"280","article-title":"Enhanced protection against respiratory influenza A infection in mice by liposome-encapsulated antibody","volume":"81","author":"Wong","year":"1994","journal-title":"Immunology"}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517315301459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517315301459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,13]],"date-time":"2023-08-13T09:48:35Z","timestamp":1691920115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517315301459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0378517315301459"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2015.08.048","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanoliposome-mediated targeting of antibodies to tumors: IVIG antibodies as a model","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2015.08.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}